H6H
VRTX icon

Hightower 6M Holding’s Vertex Pharmaceuticals VRTX Stock Holding History

Hightower 6M Holding’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-852
Closed -$240K – 354
2022
Q2 		$240K Sell
852
-1
-0.1% -$268 0.02% 217
2022
Q1 		$223K Buy
+853
New +$202K 0.02% 275

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hightower 6M Holding's VRTX Position: Q3 2022 in Review

Hightower 6M Holding sold out of Vertex Pharmaceuticals (VRTX) in Q3 2022, closing a stake of 852 shares — an estimated $240K sold.

Hightower 6M Holding first reported a position in VRTX in Q1 2022 and held it in 2 quarters. The position peaked at $240K in Q2 2022. 1,125 funds tracked by Wall St. Rank hold VRTX as of Q3 2022.

  • Hightower 6M Holding reported no remaining Vertex Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Hightower 6M Holding sold 852 Vertex Pharmaceuticals shares in Q3 2022, an estimated $240K.
  • Hightower 6M Holding first reported a position in Vertex Pharmaceuticals in Q1 2022 and held it in 2 quarters.
  • Hightower 6M Holding's Vertex Pharmaceuticals position peaked at $240K in Q2 2022.
  • 1,125 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2022.

Based on Hightower 6M Holding's 13F filing for Q3 2022, filed 25 Oct 2022.